Clinical Conductor Site Sets Standards for Functionality and Efficiency
Bio-Optronics has announced the launch of their new Clinical Conductor CTMS product line. This update enables users to modify the software homepage to suit their needs and adapt with their workflows.
Bio-Optronics has announced the launch of its new Clinical Conductor CTMS product line. This update enables users to modify the software homepage to suit their needs and adapt with their workflows. These features include: drag and drop function, “pinning” studies and a study start-up wizard.
Read the full release here
Gilead’s Yeztugo Demonstrates Strong HIV Prevention Results in Underserved Populations
July 17th 2025Results from the Phase III PURPOSE 1 (NCT04994509) and PURPOSE 2 (NCT04925752) trials highlight Yeztugo’s (lenacapavir) safety and efficacy in pregnant women, young adults, and others historically excluded from HIV prevention studies.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
